Follow on Study From RE-ALIGN
Status: | Recruiting |
---|---|
Conditions: | Cardiology |
Therapuetic Areas: | Cardiology / Vascular Diseases |
Healthy: | No |
Age Range: | Any |
Updated: | 11/11/2012 |
Start Date: | December 2011 |
Contact: | Boehringer Ingelheim Call Center |
Email: | clintriage.rdg@boehringer-ingelheim.com |
Phone: | 1-800-243-0127 |
Evaluation of the Long Term Safety of the Use of Dabigatran Etexilate in Patients With a Bileaflet Mechanical Heart Valve
To collect additional data relating to safety and indicators of efficacy for patients who
have participated in the 1160.113 study.
Inclusion criteria:
1. Completed study 1160.113 per protocol
2. Continuing need for anticoagulation
Exclusion criteria:
1. uncontrolled hypertension
2. severe renal impairment
3. active liver disease
4. increased risk of bleeding
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials